These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

63 related items for PubMed ID: 9403092

  • 1. [3 years of clinical experience with risperidone: new therapeutic standards in the management of schizophrenia].
    Nervenarzt; 1996 Oct; 67(10 Suppl Neue Thera):1-4. PubMed ID: 9403092
    [No Abstract] [Full Text] [Related]

  • 2. Risperidone in acute and long-term therapy of schizophrenia--a clinical profile.
    Pajonk FG.
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jan; 28(1):15-23. PubMed ID: 14687852
    [Abstract] [Full Text] [Related]

  • 3. [A new drug risperidone for treatment of psychosis].
    Tiihonen J.
    Duodecim; 1995 Jan; 111(20):1911-2. PubMed ID: 9841141
    [No Abstract] [Full Text] [Related]

  • 4. [3 years of risperidone: from innovation to example].
    Nervenarzt; 1997 Apr; 68(4 Suppl Von Der In):1-4. PubMed ID: 9442496
    [No Abstract] [Full Text] [Related]

  • 5. Clinical experience and management considerations with long-acting risperidone.
    Parellada E.
    Curr Med Res Opin; 2006 Feb; 22(2):241-55. PubMed ID: 16466596
    [Abstract] [Full Text] [Related]

  • 6. Clozapine and risperidone: combination/augmentation treatment of refractory schizophrenia: a preliminary observation.
    Raskin S, Katz G, Zislin Z, Knobler HY, Durst R.
    Acta Psychiatr Scand; 2000 Apr; 101(4):334-6. PubMed ID: 10782556
    [Abstract] [Full Text] [Related]

  • 7. The Canadian experience with risperidone for the treatment of schizophrenia: an overview.
    Iskedjian M, Hux M, Remington GJ.
    J Psychiatry Neurosci; 1998 Sep; 23(4):229-39. PubMed ID: 9785702
    [Abstract] [Full Text] [Related]

  • 8. Neurological soft signs and response to risperidone in chronic schizophrenia.
    Smith RC, Kadewari RP.
    Biol Psychiatry; 1996 Nov 15; 40(10):1056-9. PubMed ID: 8915566
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Risperidon: an advance for schizophrenic patients. Why new neuroleptics?].
    Nervenarzt; 1994 May 15; 65(5 Suppl [risperid]):1-4. PubMed ID: 9131087
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Schizophrenia in a 5-year-old.
    Einfeld SL, Andrews D, Selig R, Williams G, Smith C.
    Aust N Z J Psychiatry; 2005 Apr 15; 39(4):312. PubMed ID: 15777373
    [No Abstract] [Full Text] [Related]

  • 14. Expected clinical benefits of paliperidone extended-release formulation when compared with risperidone immediate-release.
    Pani L, Marchese G.
    Expert Opin Drug Deliv; 2009 Mar 15; 6(3):319-31. PubMed ID: 19317589
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Interpreting serum risperidone concentrations.
    Boerth JM, Caley CF, Goethe JW.
    Pharmacotherapy; 2005 Feb 15; 25(2):299-302. PubMed ID: 15767244
    [Abstract] [Full Text] [Related]

  • 17. Clinical evaluation of risperidone in Asian patients with schizophrenia in Singapore.
    Chong SA, Yap HL, Low BL, Choo CH, Chan AO, Wong KE, Mahendran R, Chee KT.
    Singapore Med J; 1999 Jan 15; 40(1):41-3. PubMed ID: 10361485
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [The first long-acting atypical antipsychotic: new milestone in the treatment of schizophrenia].
    Faludi G.
    Neuropsychopharmacol Hung; 2005 Mar 15; 7(1):22-7. PubMed ID: 16167464
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.